| Literature DB >> 34742855 |
Lubart Emily1, Gal Gilad2, Mizrahi Eliyahu Haim3, Goltsman Galina4.
Abstract
Clinical course of COVID-19 may be associated with functional dependency of geriatric patients. Data from the records of patients admitted to the COVID-19 Geriatric Unit were gathered during three months, including background, clinical aspects, time to resolution of infection and functional status. Functionally dependent patients had higher rates of diabetes (p = 0.03) and stroke (p = 0.004), as well as longer time to resolution of infection (p < 0.001), but less respiratory COVID-19 symptoms (p = 0.007), compared to independent patients. Time to resolution of infection was longer in women (p = 0.01) and positively associated with WBC level (p < 0.01) and age (p < 0.001). An adjusted analysis which controlled these variables confirmed the significant effect of functional status on the time to resolution of infection (p = 0.015). Functionally dependent geriatric patients with mild to moderate infection had less respiratory COVID-19 symptoms but showed longer time to resolution of infection compared to independent. Assessment of functional status in the elderly population may contribute to decision making for care of geriatric inpatients with COVID-19.Entities:
Keywords: COVID-19 symptoms; Functional dependency; Time to resolution of infection
Mesh:
Year: 2021 PMID: 34742855 PMCID: PMC8564951 DOI: 10.1016/j.exger.2021.111620
Source DB: PubMed Journal: Exp Gerontol ISSN: 0531-5565 Impact factor: 4.032
Clinical data of functionally dependent and non-functionally dependent patients.
| FDP | NFDP | χ2, p | |
|---|---|---|---|
| Hypertension | 35 (64.8) | 27 (61.4) | 0.12, 0.7 |
| Diabetes mellitus | 29 (53.7) | 14 (31.8) | 4.7, 0.03 |
| Dementia | 23 (42.6) | 15 (34.1) | 0.7, 0.39 |
| Hypercholesterolemia | 19 (35.2) | 15 (34.1) | 0.01, 0.9 |
| Osteoporosis | 14 (25.9) | 11 (25.0) | 0.01, 0.9 |
| Cerebro-vascular accident | 18 (33.3) | 4 (9.1) | 8.1, 0.004 |
| Beta-blockers | 27 (50.0) | 13 (29.5) | 4.2, 0.04 |
| Proton-pump inhibitor | 24 (44.4) | 12 (27.3) | 3.1, 0.079 |
| Angiotensin converting enzyme inhibitors | 18 (33.3) | 14 (31.8) | 0.03, 0.89 |
| Benzodiazepines | 17 (31.5) | 13 (29.5) | 0.04, 0.84 |
| Diuretics | 18 (33.3) | 10 (22.7) | 1.3, 0.25 |
| Cholesterol lowering | 3 (5.6) | 14 (31.8) | 11.7, 0.001 |
| Acetylsalicylic acid | 2 (3.7) | 12 (27.3) | 11.0, 0.001 |
| Hypnotic | 18 (33.3) | 7 (15.9) | 3.8, 0.049 |
FDP - functionally dependent patients.
NFDP – non-functionally dependent patients.
COVID-19 signs and symptoms of functionally dependent and non-functionally dependent patients.
| Symptoms | FDP | NFDP | χ2, p |
|---|---|---|---|
| Cough | 10 (18.5) | 20 (45.5) | 8.3, 0.004 |
| Headache | 6 (11) | 3 (6.8) | 0.5, 0.46 |
| Taste and smell loss | 5 (9.3) | 3 (6.8) | 0.2, 0.66 |
| Weakness | 14 (26) | 14 (31.8) | 0.4, 0.5 |
| Breathlessness | 5 (9.3) | 12 (27.3) | 5.5, 0.02 |
| Fever | 23 (42.6) | 12 (27.3) | 0.5, 0.46 |
FDP - functionally dependent patients.
NFDP – non-functionally dependent patients.
Fig. 1Mean days to resolution of infection among NFDP and FDP patients.
NFDP – non-functionally dependent patients.
FDP - functionally dependent patients.